Stock Earnings

Question 1

GLUE 最近的每股盈餘與預期相比如何？

Accepted Answer

Monte Rosa Therapeutics Inc 最近的每股盈餘為 $-0.33，not beating $-0.38 的預期。

Question 2

Monte Rosa Therapeutics Inc GLUE 上一季度的收入表現如何？

Accepted Answer

Monte Rosa Therapeutics Inc 上一季度的收入為 $-0.33

Question 3

Monte Rosa Therapeutics Inc 的收入預期是多少？

Accepted Answer

根據 9 位華爾街分析師的預測，Monte Rosa Therapeutics Inc 的收入預期範圍從 $42.0M 到 $0.0

Question 4

Monte Rosa Therapeutics Inc 的盈利品質評分是多少？

Accepted Answer

Monte Rosa Therapeutics Inc 的盈利品質評分為 B+/48.508835。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。

Question 5

Monte Rosa Therapeutics Inc 何時發布財報？

Accepted Answer

Monte Rosa Therapeutics Inc 的下一份財報預計在 2026-02-04 發布

Question 6

Monte Rosa Therapeutics Inc 的預期收益是多少？

Accepted Answer

根據華爾街分析師的預測，Monte Rosa Therapeutics Inc 的預期收益為 $5.52M

Question 7

Monte Rosa Therapeutics Inc 是否超出收益預期？

Accepted Answer

Monte Rosa Therapeutics Inc 最近的收益為 $12.76M，does not beat 預期。

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.38	$-0.33	-13.15%	MISSED
Q2 '25	$-0.39	$-0.15	-61.53%	MISSED
Q1 '25	$-0.34	$0.56	-264.7%	MISSED
Q4 '24	$-0.02	$0.23	-1.25K%	MISSED
Q3 '24	$-0.49	$-0.28	-42.85%	MISSED

Monte Rosa Therapeutics Inc (GLUE) Price